Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: ZD1839 (IRESSA)

First Posted Date: 2010-08-19

Last Posted Date: 2023-11-29

Lead Sponsor: University of Chicago

Target Recruit Count: 46

Registration Number: NCT01185158

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: ZD 1839 500mg

First Posted Date: 2010-08-19

Last Posted Date: 2023-05-11

Lead Sponsor: University of Chicago

Target Recruit Count: 70

Registration Number: NCT01185171

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients

Phase 1

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: FOLFIRI, Avastin, Irinotecan

First Posted Date: 2010-08-17

Last Posted Date: 2019-04-22

Lead Sponsor: University of Chicago

Target Recruit Count: 17

Registration Number: NCT01183494

Locations: 🇮🇹
CRO-National Cancer Institute, Aviano, Italy
🇺🇸
The University of Chicago, Chicago, Illinois, United States

Comparison of Ultrasound Guided Low Epidural Catheter Placement With Standard Epidural Catheter Placement

Completed

Conditions: Labor Pain

First Posted Date: 2010-08-16

Last Posted Date: 2016-11-01

Lead Sponsor: University of Chicago

Target Recruit Count: 90

Registration Number: NCT01182220

Locations: 🇺🇸
University of Chicago Hospitals, Chicago, Illinois, United States

Celiac Disease Database

Completed

Conditions: Celiac Disease

First Posted Date: 2010-07-30

Last Posted Date: 2024-05-16

Lead Sponsor: University of Chicago

Target Recruit Count: 1090

Registration Number: NCT01172665

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2010-07-29

Last Posted Date: 2023-11-29

Lead Sponsor: University of Chicago

Target Recruit Count: 34

Registration Number: NCT01172470

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress

Not Applicable

Completed

Conditions: Healthy Pregnant Women

Interventions: Dietary Supplement: Docosahexanoic Acid
Other: Placebo

First Posted Date: 2010-07-08

Last Posted Date: 2018-05-30

Lead Sponsor: University of Chicago

Target Recruit Count: 64

Registration Number: NCT01158976

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk

Not Applicable

Completed

Conditions: Diabetes
Sleep Apnea

Interventions: Drug: Placebo
Device: CPAP mask

First Posted Date: 2010-07-02

Last Posted Date: 2015-05-27

Lead Sponsor: University of Chicago

Target Recruit Count: 39

Registration Number: NCT01156116

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Impact of Exenatide on Sleep in Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes
Sleep Disordered Breathing

Interventions: Drug: Placebo
Drug: Exenatide

First Posted Date: 2010-06-03

Last Posted Date: 2018-09-12

Lead Sponsor: University of Chicago

Target Recruit Count: 18

Registration Number: NCT01136798

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 Diabetes

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea
Type 2 Diabetes

Interventions: Device: active CPAP Therapy
Device: sham CPAP therapy

First Posted Date: 2010-06-03

Last Posted Date: 2017-04-10

Lead Sponsor: University of Chicago

Target Recruit Count: 22

Registration Number: NCT01136785

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy